Zhendong Pharmaceutical: At present, the company has no cooperation with Real Bio Post date May 7, 2022 — 19:51 Post Lock Key Data Concepts: ? These are the company names, stock quotes, topics, and entities related to this data.300158 Shanxi Zhendong Pharmaceutical Science, Technology Pharmaceutical Financial, Business Service Paper, Packaging Product Currency Espionage, Intelligence Economics Technology, Engineering Series Economy, Business, Finance Full Data ?UNLOCK DATASubscribe & Access the Best Data and Intelligence on the Chinese Stock Markets Join Now! Need this critical market data?Access thousands of market events, data points, and news articles! Already have an account? Login Related Data Zhendong Pharmaceutical: The company has not planted vines May 17, 2022 — 10:33 Hepatitis concept, new crown treatment, traditional Chinese medicine and other pharmaceutical stocks fell May 17, 2022 — 10:27 Zhendong Pharmaceutical: Filling the blank of Chinese medicine industry standards and realizing the rapid development of Chinese medicine industry May 16, 2022 — 13:32 Zhendong Pharma helps the front line of Shanghai's anti-epidemic efforts and works together to keep "Shanghai" May 16, 2022 — 13:14 "Smart money" doomsday return to start "bottom-hunting mode" This week's northbound fund sweeping list is here! -Stock Channel-Hexun.com May 15, 2022 — 10:25 The first bioeconomy five-year plan emphasizes the quality of traditional Chinese medicine Zhendong Pharmaceutical fills the gap in industry standards May 14, 2022 — 17:17 The first bioeconomy five-year plan emphasizes the quality of traditional Chinese medicine Zhendong Pharmaceutical fills the gap in industry standards May 14, 2022 — 00:19 Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline May 13, 2022 — 11:03 Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com May 13, 2022 — 08:55 Home » News » Zhendong Pharmaceutical: At present, the company has no cooperation with Real Bio
Hepatitis concept, new crown treatment, traditional Chinese medicine and other pharmaceutical stocks fell May 17, 2022 — 10:27
Zhendong Pharmaceutical: Filling the blank of Chinese medicine industry standards and realizing the rapid development of Chinese medicine industry May 16, 2022 — 13:32
Zhendong Pharma helps the front line of Shanghai's anti-epidemic efforts and works together to keep "Shanghai" May 16, 2022 — 13:14
"Smart money" doomsday return to start "bottom-hunting mode" This week's northbound fund sweeping list is here! -Stock Channel-Hexun.com May 15, 2022 — 10:25
The first bioeconomy five-year plan emphasizes the quality of traditional Chinese medicine Zhendong Pharmaceutical fills the gap in industry standards May 14, 2022 — 17:17
The first bioeconomy five-year plan emphasizes the quality of traditional Chinese medicine Zhendong Pharmaceutical fills the gap in industry standards May 14, 2022 — 00:19
Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline May 13, 2022 — 11:03
Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com May 13, 2022 — 08:55
Caishen.CoCaishen.Co